PHELIX
USPTO Trademark Record · Serial No. 86338600
Trademark details
It was initially claimed by Fresenius Kabi AG on 20140716.
That brand applies to the following goods and services:Pharmaceutical preparations for use in extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, cellular therapies, and the treatment of infectious diseases; pharmaceutical preparations and substances for use in immune therapy, the treatment of infectious diseases, the treatment of damaged skin and tissue, inflammation, blood disorders, and viral diseases and disorders, Therapeutic medical devices for withdrawing blood from the body, separating the blood, treating the blood extracorporeally, and returning the blood to the body; therapeutic medical device used for extracorporeal photopheresis, extra corporeal photo immune therapy, extracorporeal photo chemotherapy, cellular therapies, and the treatment of infectious diseases, Therapeutic medical treatment services relating to extracorporeal photopheresis, extra corporeal photo immune therapy, extracorporeal photo chemotherapy, cellular therapies, and the treatment of infectious diseases.
Currently that trademark is represented by trademark attorney(s): Lee J. Eulgen.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the PHELIX trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
